PISCATAWAY, N.J., April 14, 2026 /PRNewswire/ -- GenScript Biotech Corporation today announced its 2025 Environmental, Social, and Governance (ESG) Report, positioning the company at the forefront of ...
GenScript Biotech Corporation (HKEX: 1548), a global company providing life science research services and products, biologics development & manufacturing services, and industrial biotechnology ...
The MarketWatch News Department was not involved in the creation of this content. The collaboration pairs Mimulus's molecular architecture with GenScript's massive synthesis scale to liberate critical ...
GenScript Is a Leader in Gene Synthesis and a CRO, CDMO, and Biotech All Rolled Into One GenScript Biotech provides life science research services and products, and is well known for its gene ...
The MarketWatch News Department was not involved in the creation of this content. PISCATAWAY, N.J., Nov. 21, 2025 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D ...
GENSCRIPT BIOTECH (01548.HK) announced that its subsidiary Legend Biotech, pursuant to its collaboration and license ...
The average one-year price target for Genscript Biotech (OTCPK:GNNSF) has been revised to $3.32 / share. This is an increase of 16.00% from the prior estimate of $2.86 dated April 1, 2025. The price ...
Article ‘Count’ and ‘Share’ for Genscript Biotech Corporation based on listed parameters only. The articles listed below published by authors from Genscript Biotech Corporation, organized by journal ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Article ‘Count’ and ‘Share’ for Genscript Biotech Corporation based on listed parameters only. According to the parameters selected above, there are no articles from Genscript Biotech Corporation from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results